Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9745311B2 · kind B2 · utility
40Cited by
27References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 14, 2016 |
| Grant date | Aug 29, 2017 |
| Priority date | — |
| Expiry date | Jun 14, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to pyrazine derivatives of Formula I, and pharmaceutical compositions including the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.